The average launch prices for new brand-name drugs and new generic drugs have skyrocketed since 2006, according to an analysis from 46brooklyn, a drug research firm. Using data from Elsevier's Gold Standard Drug Database and the federal government, the analysis found that the median monthly price of a new brand-name drug increased 381% (from $150 to $722) from 2006-2019 while the median monthly price of a new generic drug increased 712% (from about $100 to almost $800) during that period. The report also found that nearly 80% of all generic drugs studied had no decrease in their average wholesale price in the past five years.

Related News Articles

Headline
The AHA today submitted comments to House leaders on the Lower Drug Costs Now Act (H.R. 3), legislation that would make a series of changes to the Medicare…
Headline
The House Ways and Means Committee last night voted 24-17 to approve a revised version of the Lower Prescription Drug Costs Now Act.
Headline
The House Energy and Commerce Committee last night approved a revised version of the Lower Prescription Drug Costs Now Act.
Headline
Two House committees today marked up revised versions of the Lower Prescription Drug Costs Now Act (H.R. 3) — legislation that would make a series of changes…
Headline
The California Office of Statewide Health Planning and Development recently released the nation’s first mandatory data on wholesale acquisition cost increases…
Headline
Net price increases for seven drugs raised U.S. drug spending by $5.1 billion between 2017 and 2018 without evidence of improved safety or effectiveness.